Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FSLR vs GSK✓SelectedUSD · GSKFSLR vs GSK performance historyLatest closeAs of-0.53%11/13
Stock and ETF performance explorer

FSLR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+28.1%
GSK return
+65.8%
Excess return
-37.8%
Maximum drawdown
-60.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%+0.5%-1.1%-0.6%
7D-14.8%+1.1%-15.9%-14.8%
30D-4.3%+6.3%-10.6%-4.7%
3M-23.4%+1.8%-25.2%-23.4%
6M-26.9%+1.7%-28.6%-27.1%
YTD-34.4%+6.5%-40.9%-34.7%
1Y-33.2%+9.5%-42.7%-33.7%
3Y+28.1%+65.3%-37.2%+31.2%
All+28.1%+65.8%-37.8%+31.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling